Despite continuing to make acquisitions, highlighted by its C$925 million purchase of cultivator Redecan, HEXO has been in turmoil over the past 12 months, with spiraling costs and a sliding share price hampering the company as it tried to implement a plan to reduce expenses by 30% ($175 million) by the end of 2023 via a combination of cost reductions and anticipated organic revenue growth.